Funding for this research was provided by:
Eli Lilly and Company
Received: 17 October 2018
Accepted: 19 June 2019
First Online: 11 July 2019
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Chesapeake Institutional Review Board. This article does not contain any studies with animals performed by any of the authors.
: Not applicable.
: R Speck and H Shalhoub are employed by Evidera, which provides consulting and other research services to pharmaceutical, medical device, and related organizations. In their salaried positions, they work with a variety of companies and organizations, and are precluded from receiving payment or honoraria directly from these organizations for services rendered. Evidera received funding from Eli Lilly and Company to participate in the study and the development of this manuscript.